C H Mijovic
Overview
Explore the profile of C H Mijovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Britten A, Mijovic C, Barnett A, Kelly M
Int J Immunogenet
. 2009 Feb;
36(1):47-57.
PMID: 19207936
Differential expression of human leucocyte antigen (HLA) class II genes has been postulated to influence the risk of developing autoimmune disease. In this study, we investigated the relationship between the...
2.
Kelly M, Rayner M, Mijovic C, Barnett A
Mol Pathol
. 2003 Feb;
56(1):1-10.
PMID: 12560454
Type 1 diabetes is a T cell mediated autoimmune disease, characterised by the selective destruction of pancreatic beta cells, and susceptibility is determined by a combination of genetic and environmental...
3.
Rayner M, Kelly M, Mijovic C, Barnett A
Autoimmunity
. 2002 Jun;
35(2):155-7.
PMID: 12071438
The MHC class II molecule DQ6 is strongly associated with protection from type 1 diabetes. A small number of diabetic subjects have been typed as positive for DQ6, but it...
4.
Kelly M, Rayner M, Mijovic C, Barnett A
Scand J Immunol
. 2002 May;
55(6):599-605.
PMID: 12028563
The HLA class II molecule, DQ6, confers strong natural protection against the development of type 1 diabetes. The mechanism of disease protection is unknown, but is likely to be related...
5.
Heward J, Mijovic C, Kelly M, Morrison E, Barnett A
Eur J Immunogenet
. 2002 Feb;
29(1):47-52.
PMID: 11841488
Genetic susceptibility to type 1 diabetes is determined by a combination of HLA-DQ and DRB1 alleles. In the present study, HLA associations with type 1 diabetes were investigated in the...
6.
Kelly M, Mijovic C, Barnett A
Best Pract Res Clin Endocrinol Metab
. 2001 Sep;
15(3):279-91.
PMID: 11554771
Type 1 diabetes mellitus is a T-cell-mediated autoimmune disease characterized by the selective destruction of pancreatic beta cells. Susceptibility to the disease is determined by a combination of genetic and...
7.
Hermann R, Mijovic C, Rayner M, Croft N, Kelly M, Jenkins D, et al.
Hum Immunol
. 2001 Apr;
62(4):391-8.
PMID: 11295472
It has been postulated that variation in the distribution of human leukocyte antigen (HLA)-encoded susceptibility alleles for insulin-dependent diabetes mellitus (IDDM) is the genetic basis for variation in the incidence...
8.
Kelly M, Chan J, Heward J, Mijovic C, Zimmet P, Yeung V, et al.
Diabet Med
. 2001 Feb;
18(1):22-8.
PMID: 11168337
Aims: A study of the Hong Kong Chinese showed that the majority of subjects with young-onset diabetes (age of diagnosis < 35 years) present with a phenotype suggestive of Type...
9.
McTernan C, Stewart L, Mijovic C, Barnett A
Diabet Med
. 2000 Oct;
17(9):661-6.
PMID: 11051286
Aims: Whilst HLA-DRB1 and HLA-DQ alleles contribute to IDDM1, the major determinant of genetic susceptibility to Type 1 diabetes mellitus, other major histocompatibility complex (MHC)-encoded genes may also be involved....
10.
McTernan C, Mijovic C, Cockram C, Barnett A
Tissue Antigens
. 2000 Aug;
56(1):95-8.
PMID: 10958363
The HLA-DP genes (HLA-DPA1 and -DPB1) are encoded by the major histocompatibility complex (MHC) on human chromosome 6. They are involved in the presentation of antigen to CD4+ T cells...